Janssen Pharmaceutical Collaborates with Stiching International Dispensary Association

Published on: 

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014, Volume 10, Issue 5

Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.

Johnson & Johnson reported its affiliate Janssen Pharmaceutical NV has entered into a collaboration with the Stiching International Dispensary Association (IDA), a procurement agent for the Stop TB Partnership’s Global Drug Facility (GDF), to facilitate access to the company’s anti-tuberculosis medicine. This public-private partnership was established by the newly formed Janssen Global Public Health, to help improve overall public health.

More than 130 low- and middle-income countries outside of the US will now be able to obtain this new anti-tuberculosis medicine through the procurement processes of GDF and its agent, the IDA.


Source: Johnson & Johnson